154 related articles for article (PubMed ID: 19105161)
1. [Alternative agents used in ADHD].
Hässler F; Dück A; Reis O; Buchmann J
Z Kinder Jugendpsychiatr Psychother; 2009 Jan; 37(1):13-24, quiz 24-5. PubMed ID: 19105161
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
Wilens TE
J Clin Psychiatry; 2006; 67 Suppl 8():32-8. PubMed ID: 16961428
[TBL] [Abstract][Full Text] [Related]
3. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
Rowles BM; Findling RL
Dev Disabil Res Rev; 2010; 16(3):273-82. PubMed ID: 20981766
[TBL] [Abstract][Full Text] [Related]
4. Innovations and recent trends in the treatment of ADHD.
Madaan V; Kinnan S; Daughton J; Kratochvil CJ
Expert Rev Neurother; 2006 Sep; 6(9):1375-85. PubMed ID: 17009924
[TBL] [Abstract][Full Text] [Related]
5. The potential for misuse and abuse of medications in ADHD: a review.
Clemow DB; Walker DJ
Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
[TBL] [Abstract][Full Text] [Related]
6. Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.
Waxmonsky JG
Essent Psychopharmacol; 2005; 6(5):262-76. PubMed ID: 16222911
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of attention deficit hyperactivity disorder.
Spencer T; Biederman J; Wilens T
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):77-97. PubMed ID: 10674191
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
Faraone SV; Glatt SJ
J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
[TBL] [Abstract][Full Text] [Related]
9. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
[TBL] [Abstract][Full Text] [Related]
10. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
[TBL] [Abstract][Full Text] [Related]
11. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
[TBL] [Abstract][Full Text] [Related]
12. [Adult attention deficit/hyperactivity disorder].
Laufkötter R; Eichhammer P; Hajak G
MMW Fortschr Med; 2004 Aug; 146(33-34):31-4. PubMed ID: 15526623
[TBL] [Abstract][Full Text] [Related]
13. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
14. Attention-deficit/hyperactivity disorder: management.
Szymanski ML; Zolotor A
Am Fam Physician; 2001 Oct; 64(8):1355-62. PubMed ID: 11681777
[TBL] [Abstract][Full Text] [Related]
15. Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents.
Faraone SV; McBurnett K; Sallee FR; Steeber J; López FA
Clin Ther; 2013 Nov; 35(11):1778-93. PubMed ID: 24139092
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
[TBL] [Abstract][Full Text] [Related]
17. Addressing comorbidity in adults with attention-deficit/hyperactivity disorder.
Hornig M
J Clin Psychiatry; 1998; 59 Suppl 7():69-75. PubMed ID: 9680055
[TBL] [Abstract][Full Text] [Related]
18. [Algorithms for the medical treatment of Attention-Deficit/Hyperactivity Disorder with specific co-morbidities].
Frölich J; Lehmkuhl G; Döpfner M
Z Kinder Jugendpsychiatr Psychother; 2010 Jan; 38(1):7-20. PubMed ID: 20047172
[TBL] [Abstract][Full Text] [Related]
19. Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.
Merkel RL
Expert Opin Drug Saf; 2010 Nov; 9(6):917-35. PubMed ID: 20615078
[TBL] [Abstract][Full Text] [Related]
20. Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.
Marcus SC; Durkin M
J Am Acad Child Adolesc Psychiatry; 2011 May; 50(5):480-9. PubMed ID: 21515197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
